id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2023-0168-0156,DEA,DEA-2023-0168,"Hearings, Meetings, Proceedings, etc.: Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine and 2,5-dimethoxy-4-chloroamphetamine in Schedule I; Stay",Proposed Rule,,2024-06-07T04:00:00Z,2024,6,2024-06-07T04:00:00Z,,2024-06-07T16:05:43Z,2024-12504,0,0,090000648659daf8
DEA-2023-0168-0155,DEA,DEA-2023-0168,"Hearings, Meetings, Proceedings, etc.: Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine and 2,5-dimethoxy-4-chloroamphetamine in Schedule I",Proposed Rule,,2024-04-09T04:00:00Z,2024,4,2024-04-09T04:00:00Z,,2024-06-07T16:06:39Z,2024-07473,0,0,09000064864c2af7
DEA-2023-0168-0004,DEA,DEA-2023-0168,FINAL SIGNED ASH Letter to DEA_DOI-DOC_09.28.2020,Supporting & Related Material,,2023-12-14T05:00:00Z,2023,12,,,2023-12-14T16:35:38Z,,0,0,090000648633a0c2
DEA-2023-0168-0005,DEA,DEA-2023-0168,DEA1156 Eight-Factor Review DOI DOC 102023,Supporting & Related Material,,2023-12-14T05:00:00Z,2023,12,,,2023-12-14T16:35:46Z,,0,0,090000648633a0c3
DEA-2023-0168-0001,DEA,DEA-2023-0168,"Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine and 2,5-dimethoxy-4-chloroamphetamine in Schedule I",Proposed Rule,,2023-12-13T05:00:00Z,2023,12,2023-12-13T05:00:00Z,2024-01-13T04:59:59Z,2024-01-13T20:44:04Z,2023-27289,0,0,09000064863304b8